Emergent Biosolutions (EBS) Reports Q2 EPS of 13c
Tweet
Share
E-mailGet Alerts EBS Hot Sheet
Price: $6.76 +3.21%
Revenue Growth %: -45.6%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -45.6%
Financial Fact:
Selling, general and administrative: 40.69M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Emergent Biosolutions (NYSE: EBS) reported Q2 EPS of $0.13, may not compare to the analyst estimate of $0.32. Revenue for the quarter came in at $110.3 million versus the consensus estimate of $109.25 million.
For earnings history and earnings-related data on Emergent Biosolutions (EBS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- Sun Communities completes $1.03B sale of Park Holidays to Aermont
- UBS Reiterates Neutral Rating on Pilgrim's Pride (PPC) on 'Challenging' Near-Term Fundamentals
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
